Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Ezetimibe, a selective inhibitor of the transport of cholesterol Miura S; Saku KIntern Med 2008[]; 47 (13): 1165-70Niemann-Pick C1-like 1 (NPC1L1) has recently been identified and has been shown to have features of a plasma membrane transporter, including a secretion signal, 13 predicted transmembrane domains, extensive N-linked glycosylation sites and a sterol-sensing domain. It is highly expressed on the surface of absorptive jejunal enterocytes. NPC1L1 has been shown to be a direct target of ezetimibe, and an ezetimibe-sensitive pathway plays a role in intestinal cholesterol absorption. Ezetimibe-based therapy represents an exciting new area in the treatment of dyslipidemia.|Animals[MESH]|Anticholesteremic Agents/*pharmacology[MESH]|Azetidines/*pharmacology[MESH]|Cholesterol/metabolism[MESH]|Clinical Trials as Topic[MESH]|Drug Therapy, Combination[MESH]|Ezetimibe[MESH]|Humans[MESH]|Hypercholesterolemia/drug therapy/metabolism[MESH]|Membrane Proteins/*drug effects/metabolism[MESH]|Membrane Transport Proteins[MESH]|Mice[MESH]|Protein Structure, Secondary[MESH] |